Capstone Investment Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,065
| Closed | -$800K | – | 1115 |
|
|
2024
Q1 | $800K | Buy |
19,065
+6,412
| +51% | +$269K | ﹤0.01% | 628 |
|
|
2023
Q4 | $502K | Buy |
+12,653
| New | +$502K | ﹤0.01% | 516 |
|
|
2021
Q1 | – | Sell |
-26,829
| Closed | -$470K | – | 640 |
|
|
2020
Q4 | $470K | Buy |
+26,829
| New | +$470K | ﹤0.01% | 295 |
|